Clinical Development
Gilead Sciences, Inc.
Foster City, California, United States
Joe Llewellyn, PharmD
Senior Director, Virology Clinical Development
Gilead Sciences Inc.
Joe has worked at Gilead for the past 10 years with a focus on viral hepatitis and emerging and respiratory viruses. Prior to joining Gilead, Joe worked as a clinical pharmacist at the University of New Mexico Hospital in Albuquerque, where he also served on the Project ECHO clinical team treating hepatitic C.
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)
92 - Obeldesivir Reduced SARS-CoV-2 Infectious Titers in the BIRCH Phase 3 Clinical Trial
Thursday, October 17, 2024
11:30 AM – 11:43 AM US PT